Valuation: FDC Limited

Market Cap 52.81B 545M 487M 454M 413M 776M 784M 5.45B 2.13B 26.83B 2.05B 2B 86.3B P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 47.75B 493M 440M 411M 373M 702M 709M 4.93B 1.93B 24.26B 1.85B 1.81B 78.03B EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day-1.37%
1 week-4.52%
Current month-4.52%
1 month-5.29%
3 months-23.96%
6 months-4.47%
Current year-23.41%
1 week 321.4
Extreme 321.4
339.9
1 month 321.4
Extreme 321.4
365.6
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
473.6
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 18/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 23/10/2025
Director TitleAgeSince
Director/Board Member 63 30/09/1993
Director/Board Member 48 31/12/2001
Director/Board Member 85 15/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-4.52% - - 553M
-1.61%+1.08%+38.64%+106.93% 1,060B
-0.76%-3.12%+35.78%+62.70% 623B
+0.39%+4.14%+17.00%+83.77% 480B
-0.29%-2.02%+62.52%+37.06% 352B
-2.03%+1.03%+22.25%+42.16% 345B
-1.92%-1.87%+11.94%+33.20% 274B
-2.36%-3.16%-6.95%+8.68% 249B
-1.37%-3.34%+37.86%+52.33% 223B
+0.17%-1.31%+25.96%+96.82% 182B
Average -1.50%-0.48%+27.22%+58.18% 420.89B
Weighted average by Cap. -1.39%+0.04%+30.57%+68.82%

Financials

2025 2026
Net sales 21.08B 218M 194M 181M 165M 310M 313M 2.18B 852M 10.71B 817M 800M 34.45B 21.71B 224M 200M 187M 170M 319M 322M 2.24B 877M 11.03B 842M 823M 35.48B
Net income 2.67B 27.55M 24.6M 22.95M 20.85M 39.23M 39.61M 276M 108M 1.36B 103M 101M 4.36B 2.81B 29.06M 25.95M 24.21M 21.99M 41.38M 41.78M 291M 114M 1.43B 109M 107M 4.6B
Net Debt -5.15B -53.17M -47.48M -44.29M -40.24M -75.72M -76.45M -532M -208M -2.62B -200M -195M -8.42B -5.06B -52.25M -46.66M -43.53M -39.54M -74.41M -75.13M -523M -204M -2.57B -196M -192M -8.27B
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
08/10/26 ₹324.05 -1.37% 113,874
07/10/26 ₹328.55 -1.53% 84,094
06/10/26 ₹333.65 +0.71% 113,050
05/10/26 ₹331.30 -1.37% 90,007
01/10/26 ₹335.90 -1.03% 107,854
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B